Zacks Research Has Positive Outlook for IRWD Q3 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings estimates for Ironwood Pharmaceuticals in a research note issued to investors on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the biotechnology company will earn $0.08 per share for the quarter, up from their previous […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings estimates for Ironwood Pharmaceuticals in a research note issued to investors on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the biotechnology company will earn $0.08 per share for the quarter, up from their previous […]
